While we're talking about funding basic research - how come these independent institutes and government funding agencies don't get equity (warrants, options, whatever) in the entities that ultimately commercialize and patent this research?
I reckon they probably take some cut as a licensing fee, but seems like participating in the upside would create significant incentives over the current regimes.
I reckon they probably take some cut as a licensing fee, but seems like participating in the upside would create significant incentives over the current regimes.